New Key Statistics Module, Z-Score and F-Score
NAS:ITOS Key Ratios
| Market Cap $ M | 419.35 |
| Enterprise Value $ M | -111.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.73 |
| Price/Sales | 32.43 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 12.00 |
| EPS (TTM) $ | -3.15 |
| Beneish M-Score | 43.84 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -216.60 |
| EV-to-EBIT | 0.76 |
| EV-to-EBITDA | 0.77 |
| PEG | -- |
| Shares Outstanding M | 35.97 |
| Net Margin (%) | -894.35 |
| Operating Margin % | -1,149.37 |
| Pre-tax Margin (%) | -865.66 |
| Quick Ratio | 13.76 |
| Current Ratio | 13.76 |
| ROA % (ttm) | -15.94 |
| ROE % (ttm) | -18.09 |
| ROIC % (ttm) | -140.71 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.35 |
ITOS Number of Guru Trades
ITOS Volume of Guru Trades
Gurus Latest Trades with NAS:ITOS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ITOS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ITeos Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ITOS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers